Oxford Instruments PLC Announces Share Buyback Transactions

Oxford Instruments PLC, a leading UK-based company specializing in advanced instrumentation equipment, has continued its share buyback programme, as announced on 25 June 2025. The company, listed on the London Stock Exchange, has been actively purchasing its own shares for cancellation, impacting its share structure and potentially influencing its market valuation.

Recent Transactions

On 17 July 2025, Oxford Instruments purchased 26,720 of its own ordinary shares at an average price of 2006.8820 pence per share. The transaction, executed through Numis Securities Limited, saw the lowest price paid per share at 1994.0000 pence and the highest at 2010.0000 pence. Following this purchase, the total number of ordinary shares in issue was reduced to 58,025,069, with the company holding no shares in treasury, maintaining the total number of voting rights at 58,025,069.

The day prior, on 16 July 2025, the company acquired 34,728 shares at an average price of 2005.1490 pence per share. The lowest and highest prices paid were 1988.0000 pence and 2020.0000 pence, respectively. This transaction adjusted the total number of shares in issue to 58,051,789, with voting rights remaining unchanged at 58,051,789.

Earlier, on 15 July 2025, Oxford Instruments bought back 14,904 shares at an average price of 2023.0183 pence per share. The transaction ranged from 2010.00 pence to 2035.00 pence per share, resulting in a total of 58,086,517 shares in issue post-cancellation, with voting rights also at 58,086,517.

Financial Overview

As of 16 July 2025, Oxford Instruments’ close price stood at 2010 pence, with a 52-week high of 2580 pence on 31 July 2024, and a 52-week low of 1470 pence on 6 April 2025. The company’s market capitalization is valued at 1.17 billion GBP, with a price-to-earnings ratio of 45.38. Operating within the Information Technology sector, specifically in electronic equipment, instruments, and components, Oxford Instruments is recognized for its contributions to scientific research, chemical analysis, patient monitoring, semiconductor processing, and diagnostic imaging.

Conclusion

Oxford Instruments PLC’s ongoing share buyback programme reflects its strategic financial management and commitment to shareholder value. By reducing the number of shares in issue, the company potentially enhances its earnings per share and strengthens its market position. As the programme continues, stakeholders will closely monitor its impact on the company’s financial health and market performance.